"Immunocompromised Host" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
| Descriptor ID |
D016867
|
| MeSH Number(s) |
G12.470
|
| Concept/Terms |
Immunocompromised Host- Immunocompromised Host
- Host, Immunocompromised
- Hosts, Immunocompromised
- Immunocompromised Hosts
- Immunocompromised Patient
- Immunocompromised Patients
- Patient, Immunocompromised
- Patients, Immunocompromised
- Immunosuppressed Host
- Host, Immunosuppressed
- Hosts, Immunosuppressed
- Immunosuppressed Hosts
|
Below are MeSH descriptors whose meaning is more general than "Immunocompromised Host".
Below are MeSH descriptors whose meaning is more specific than "Immunocompromised Host".
This graph shows the total number of publications written about "Immunocompromised Host" by people in this website by year, and whether "Immunocompromised Host" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 2 | 2 | 4 |
| 2003 | 4 | 2 | 6 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 1 | 4 | 5 |
| 2010 | 0 | 1 | 1 |
| 2011 | 4 | 4 | 8 |
| 2012 | 1 | 0 | 1 |
| 2013 | 2 | 1 | 3 |
| 2014 | 2 | 2 | 4 |
| 2015 | 2 | 1 | 3 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 3 | 4 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 2 | 2 |
| 2020 | 2 | 2 | 4 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunocompromised Host" by people in Profiles.
-
Leblond AL, Helmchen B, Ankavay M, Lenggenhager D, Jetzer J, Helmchen F, Yurtsever H, Parrotta R, Healy ME, P?schel A, Markkanen E, Semmo N, Ferri? M, Cocquerel L, Seeger H, Hopfer H, M?llhaupt B, Gouttenoire J, Moradpour D, Gaspert A, Weber A. HEV ORF2 protein-antibody?complex deposits are associated with glomerulonephritis in hepatitis E with reduced immune status. Nat Commun. 2024 Oct 14; 15(1):8849.
-
Sun G, Weiss A, Zhao J, Silver M, DeMaio M, Dehbashi S. Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult. BMJ Case Rep. 2023 Aug 27; 16(8).
-
Kato TS, Gomi H, Eisen HJ, Hunt SA. How to preserve information equity for COVID-19 vaccination among severely immunocompromised populations: Challenges among heart transplant recipients in Japan. Clin Transplant. 2022 09; 36(9):e14765.
-
Vuille-Lessard ?, Montani M, Bosch J, Semmo N. Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun. 2021 09; 123:102710.
-
Mostyka M, Shia J, Neumann WL, Whitney-Miller CL, Feely M, Yantiss RK. Clinicopathologic Features of Varicella Zoster Virus Infection of the Upper Gastrointestinal Tract. Am J Surg Pathol. 2021 02 01; 45(2):209-214.
-
Rossi R, Rellosa N, Miller R, Schultz CL, Miller JM, Berman L, Miller EG. A Complicated Case of Vaccine Refusal. Pediatrics. 2020 10; 146(4).
-
Lindell RB, Nishisaki A, Weiss SL, Traynor DM, Fitzgerald JC. Risk of Mortality in Immunocompromised Children With Severe Sepsis and Septic Shock. Crit Care Med. 2020 07; 48(7):1026-1033.
-
Gittens AT, Clarke JD, Abdelbaki S, Kwon JS. A 72-Year-Old Man With a Violaceous Rash?and Sepsis. Chest. 2020 02; 157(2):e41-e45.
-
Allam SR, Madhrira MM, Memon IA, Tessier J, Johnson JA, Dao A, Rofaiel G. Invasive mucormycosis in a renal transplant recipient. Kidney Int. 2020 01; 97(1):216.
-
Wolf R, Parish LC, Parish JL. The rash from nuisance to life threatening: Part II. Clin Dermatol. 2020 Jan - Feb; 38(1):1-2.